RegCell's Groundbreaking Research on Antigen-Specific Tolerance Paves the Way for Autoimmune Disease Treatment RegCell has announced two crucial peer-reviewed studies demonstrating the potential of antigen-specific tolerance in treating autoimmune diseases through T cell reprogramming.

RegCell's Groundbreaking Research on Antigen-Specific Tolerance Paves the Way for Autoimmune Disease Treatment #USA #Emeryville #RegCell #Shimon_Sakaguchi #Tregs

Dr. Shimon Sakaguchi Receives Nobel Prize for Revolutionary Treg Discoveries in Medicine RegCell's co-founder, Dr. Shimon Sakaguchi, has been honored with the 2025 Nobel Prize in Physiology for his vital contributions to immunology.

Dr. Shimon Sakaguchi Receives Nobel Prize for Revolutionary Treg Discoveries in Medicine #United_States #Emeryville #Nobel_Prize #RegCell #Shimon_Sakaguchi